Cardiac POCT - CK-MB Immunoassay Test Kit
CK-MB diagnostic test is a proprietary point-of-care fluorescence immunoassay (FIA) designed for prompt and accurate in-vitro quantitative measurement
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Brand name
- Optical Q
- Payment Terms
- T/T
- Production method
- OBM
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- diagnostic devices, ivd, poct, fluorescence immunoassay
- Category
- Chemical Reagents & Products
Product name | Cardiac POCT - CK-MB Immunoassay Test Kit | Certification | CE |
---|---|---|---|
Category | Chemical Reagents & Products | Material | - |
Keyword | diagnostic devices , ivd , poct , fluorescence immunoassay | Unit Size | - |
Brand name | Optical Q | Unit Weigh | - |
origin | South Korea | Stock | 100000 |
Supply type | OBM | HS code | 3822 |
Product Information
The Optical Q™ CK-MB diagnostic test is a proprietary point-of-care (POCT) fluorescence immunoassay (FIA) designed for prompt and accurate in-vitro quantitative measurement of CK-MB.
Creatine Kinase-MB (CK-MB) is a form of enzyme found primarily in heart muscle cells. CK-MB is one of three forms of the enzyme creatine kinase and is released from the muscle cells and is detectable in the blood when there is muscle damage in the heart. When there is an increased presence of CK-MB in the blood, the CK-MB test can be used to determine whether it is a heart damage or not.
The Optical Q™ CK-MB reagent test is thus used for assisting diagnoses of acute myocardial infraction, heart attack, distinguish between skeletal muscle and heart muscle damage, and monitor additional heart damage.
Specifications
Working range | 3.0-100.0 ng/ml |
Reference range | ≤5 ng/ml |
CV | <10% |
Sample type | Serum / Plasma |
Sample volume | 100 µL |
Loading volume | 100 µL |
Assay time | 15 minutes |
Storage condition | Cartridge: 2-30 °C / Detection buffer: 2-8 °C |
Shelf life | 24 months |
Ordering Information
Cat No. | Description | Packing Size | Storage Condition |
OB143-25 | Optical Q CK-MB | 25 Test/Box | Cartridge: 2-30℃ Detection Buffer: 2-8℃ |
- Product Info Attached File
- Verified Certificate
-
B2B Trade
Price (FOB) | Negotiable | transportation | Air Transportation,Negotiation Other |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | T/T | Shipping time | Negotiable |
- President
- Jeawon Kim, Minyoung Choi
- Address
- Bonbukwan-401, 76, Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Korea
- Product Category
- Other Monitoring & Diagnostic Equipment
- Year Established
- 2019
- Company introduction
-
OptiBio is a South Korean in-vitro diagnostics (IVD) company focused in researching, developing, and manufacturing cutting edge fluorescence immunoassay (FIA) solutions. In 2020, OptiBio was selected by a research fund sponsored by the Bill & Melinda Gates foundation for its unique and dedicated approach to immunoassay.
OptiBio's competitive advantage stems from its strong foundation of experts, each specialized in fields crucial for product development. Our R&D is divided into 3 different teams of scientists and engineers dedicated to the independent development of diagnostic markers, test kits, and analyzers.
Our fundamental approach to in-house specialization allows OptiBio to constantly improve our product performance, customize our solutions based on client feedback, develop new test parameters, and respond to changing market needs.
OptiBio will continue to create, improve, and innovate world-class diagnostic solutions in the field of fluorescence immunoassay and point-of-care testing (POCT). Through this, we aim to ultimately transform medical diagnosis into a universally available right.
- Main Markets
-
Brazil
Ethiopia
Germany
Mexico
Nigeria
- Main Product
- Attached File
Related Products
Influenza Virus A/B Detection Kit
HTPB (Hydroxyl-terminated polybutadiene)
Fully Automated Protein Synthesis/purification
Influenza Virus A/B & A Subtype Detection Kit
ICG-1000